Betacellulin: defining a novel sub-type in schizophrenia [ 1/1/2021 - 12/31/2023 ]

Research Grant

Brief description Schizophrenia is a severe lifelong mental disorder affecting 0.7% of the world population with only partially effective symptomatic treatments. Its cause is unknown and thus cures cannot be developed currently. A promising candidate is betacellulin a growth factor which is very reduced in the brain and blood of people with schizophrenia. Little is known about its role in the brain and this project seeks to identify its relevance to schizophrenia as a step to develop new treatments.

Funding Amount $907,515

Funding Scheme Ideas Grants

Chief Investigator Prof Suresh Sundram

Notes Ideas Grants